The business model of CZ Vaccines is based on the research and development in the Biotechnology field. That is why CZ Vaccines makes strong efforts to invest and annually allocates 11% of its sales to this end.
The R&D department counts on a dynamic young staff with a long scientific track record who keep abreast of state of the art technologies to face the most demanding biotechnology challenges. They collaborate continually with Universities and Institutions worldwide to develop new and ambitious products.
The modern R&D laboratory with sophisticated equipment allows them to develop products from the initial phases of research.
Aside from this, the registration department has extensive experience worldwide and in Europe in the field of pharmaceutical regulation, from the presentation of the registartion until the authorisation of the medicine for ots commercialisation and counts on a wide portfolio of projects to their credit.
FungitechOnco: A project for the industrial research into cultivation of medicinal fungus species to obtain new compounds with anti cancerigenous qualities applicable in products oriented towards the prevention and treatment of gastric and colorectal cancer.
Projects subsidised by the Centre for Industrial Technological Development (CDTI), co-financed with European Union structural funds and supported by the Ministry of Economy and Competitiveness. Multiregional Operational Programme for Intelligent Growth 2014-2020.